Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ckj/sfv133 http://scihub22266oqcxt.onion/10.1093/ckj/sfv133 C4792612!4792612!26985370     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Kidney+J 2016 ; 9 (2): 205-10 Nephropedia Template TP {{tp|p=26985370|t=2016. Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy |pdf=|usr=}}{{26985370}} gab.com Text Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy JO: Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=26985370 #FOAvip Background: Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods: We retrospectively analysed 112 patients treated with CRRT at Skåne University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results: Hypophosphataemia (<0.7 mM) occurred in 15% of the treatment days in the control group compared with 7% in the study group (P = 0.027). Magnesium substitution was reduced by 40% in the study group (P < 0.001). No differences in acid?base parameters were detected between the groups. Conclusions: In this larger cohort, we could confirm that Phoxilium® reduced the episodes of hypophosphataemia during CRRT. A beneficial effect on magnesium balance could also be observed. Twit Text FOAVip Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy ????Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=26985370 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26985370 #FOAvip English Wikipedia <ref>{{Cite pmid|26985370}}</ref> Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy #MMPMID26985370 Godaly G; Carlsson O; Broman M Clin Kidney J 2016[Apr]; 9 (2): 205-10 PMID26985370show ga Background: Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods: We retrospectively analysed 112 patients treated with CRRT at Skåne University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results: Hypophosphataemia (<0.7 mM) occurred in 15% of the treatment days in the control group compared with 7% in the study group (P = 0.027). Magnesium substitution was reduced by 40% in the study group (P < 0.001). No differences in acid?base parameters were detected between the groups. Conclusions: In this larger cohort, we could confirm that Phoxilium® reduced the episodes of hypophosphataemia during CRRT. A beneficial effect on magnesium balance could also be observed. äPhoxilium® reduces hypophosphataemia and magnesium supplementation dur(epmc).pdf DeepDyve Pubget Overpricing